Robuta

https://pubmed.ncbi.nlm.nih.gov/21050422/ Present and future evolution of advanced breast cancer therapy Although the introduction of novel therapies and drug combinations has improved the prognosis of metastatic breast cancer, the disease remains incurable.... present and futureadvanced breast cancerevolutiontherapy https://curingwithsound.podbean.com/e/ep16-treating-advanced-breast-cancer-with-noninvasive-focused-ultrasound-and-radiation-a-conversation-with-dr-gregory-czarnota/ Ep16: Treating Advanced Breast Cancer with Noninvasive Focused Ultrasound and Radiation: A... In recognition of Breast Cancer Awareness Month, Dr. Greg Czarnota, a senior scientist and radiation oncologist at Sunnybrook Research Institute in Toronto,... advanced breast cancer https://www.cochrane.org/de/evidence/CD008926_toremifene-versus-tamoxifen-advanced-breast-cancer Toremifene versus tamoxifen for advanced breast cancer | Cochrane advanced breast cancerversustamoxifencochrane https://www.nice.org.uk/guidance/ta421/history History | Everolimus with exemestane for treating advanced breast cancer after endocrine therapy |... Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy advanced breast cancer https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1598069/full Frontiers | Survival prognosis evaluation in advanced breast cancer patients: a study on the... BackgroundInflammation and nutritional status play critical roles in tumor initiation and progression. Advanced Lung Cancer Inflammation Index (ALI) has gain... advanced breast cancer https://www.feinberg.northwestern.edu/research/podcast/improving-survival-for-advanced-breast-cancer-with-massimo-cristofanilli-md.html Improving Survival for Advanced Breast Cancer with Massimo Cristofanilli, MD Research: Feinberg... Massimo Cristofanilli, MD, talks about the state of breast cancer in America today. advanced breast cancer https://pubmed.ncbi.nlm.nih.gov/31755729/ Level III dissection in locally advanced breast cancer following neoadjuvant chemotherapy: a... Level III positivity rate is high and so cannot be avoided in locally advanced breast cancer following neoadjuvant chemotherapy. None of the preoperative... advanced breast cancerlevel iii https://www.advancedbreastcancergroup.org.au/ Advanced Breast Cancer Group Advanced Breast Cancer Group - Dedicated support group for women Aug 12, 2025 - Welcome to the website for the Advanced Breast Cancer Group. We are a Queensland- wide service specifically developed to support women with secondary breast... advanced breast cancerdedicated supportgroupwomen https://www.nice.org.uk/guidance/ng101/chapter/Recommendations Recommendations | Early and locally advanced breast cancer: diagnosis and management | Guidance |... This guideline covers diagnosing and managing early and locally advanced breast cancer. It aims to help healthcare professionals offer the right treatments to... advanced breast cancerrecommendationsearlylocallydiagnosis https://pmc.ncbi.nlm.nih.gov/articles/PMC10561652/ Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer - PMC Among breast cancers without human epidermal growth factor receptor 2 (HER2) amplification, overexpression, or both, a large proportion express low levels of... advanced breast cancertrastuzumab deruxtecanpreviouslytreated https://www.nice.org.uk/guidance/ta421/chapter/3-Evidence 3 Evidence | Everolimus with exemestane for treating advanced breast cancer after endocrine therapy... Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy advanced breast cancer https://pubmed.ncbi.nlm.nih.gov/26640370/ Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical... This real-life study shows that nab-paclitaxel has a significant antitumor activity and a manageable safety profile in patients pretreated with taxanes and... advanced breast cancerprospective study https://www.sciencedaily.com/releases/2004/05/040519065148.htm Drug Combo Effective For Advanced Breast Cancer | ScienceDaily advanced breast cancerdrugcomboeffectivesciencedaily https://www.nice.org.uk/guidance/TA421/chapter/1-Recommendations 1 Recommendations | Everolimus with exemestane for treating advanced breast cancer after endocrine... Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy advanced breast cancer https://ce.massmed.nejm.org/nejm-weekly-cme/content/overall-survival-ribociclib-plus-fulvestrant-advanced-breast-cancer Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer | MMS/NEJM Continuing... advanced breast cancer https://advancedbreastcancer.net/ Advanced Breast Cancer Health Info & Community Learn, educate, and connect with peers and healthcare professionals in an online community for those affected by Advanced Breast Cancer. advanced breast cancerhealth infocommunity https://www.news-medical.net/news/20250618/New-switchable-CAR-T-therapy-enters-phase-1-trial-for-advanced-breast-cancer.aspx New switchable CAR-T therapy enters phase 1 trial for advanced breast cancer Jun 18, 2025 - The Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a milestone in cancer treatment with... https://pubmed.ncbi.nlm.nih.gov/18502088/?dopt=Abstract Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future... The studies assessed were heterogeneous with regard to patient selection and chemotherapy regimens used. A complete pathological response is the strongest... https://pubmed.ncbi.nlm.nih.gov/39286738/ Curcumin's effect in advanced and metastatic breast cancer patients treated with first or... In this study, we showed for the first time that adding oral curcumin for advanced and metastatic breast cancer patients treated with first or second-line... https://boris-portal.unibe.ch/entities/publication/621a2804-e410-4bfb-840c-dd18a048d631 Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer... BACKGROUND HER2-positive breast cancers usually contain large amounts of T-cell infiltrate. We hypothesised that trastuzumab resistance in HER2-positive breast... pembrolizumabplustrastuzumabresistantadvanced https://about.uq.edu.au/experts/project/7859 Improved Early Detection Of Breast Cancer Enabled By Grid-Computing And Advanced Modelling And... https://pmc.ncbi.nlm.nih.gov/articles/PMC11043241/ Tumor lysis syndrome following letrozole for locally advanced breast cancer: a case report - PMC Letrozole, an aromatase inhibitor, is used to treat breast cancer in postmenopausal women. Tumor lysis syndrome (TLS) is a complication that can trigger... tumor lysis syndrome https://news.cancerresearchuk.org/2024/01/25/talazoparib-brca-genes-targeted-advanced-breast-cancer-treatment-nhs/ NHS offers first drug targeting advanced breast cancers driven by BRCA gene mutations - Cancer... Jan 21, 2026 - Around 300 people in England can receive talazoparib, which can stop advanced breast cancers with BRCA gene mutations growing for longer. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1096571/full Frontiers | Prediction of clinical response to neoadjuvant therapy in advanced breast cancer by... Neoadjuvant therapy (NAT) is the preferred treatment for advanced breast cancer nowadays. The early prediction of its responses is important for personalized... https://pubmed.ncbi.nlm.nih.gov/28903361/ Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer... The observational prospective trial herein presented aimed at evaluating the efficacy of fulvestrant 500 mg in the treatment of endocrine sensitive advanced... endocrine therapysensitive advancedfulvestrantmilligrams https://pubmed.ncbi.nlm.nih.gov/29497278/ Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2- advanced breast cancer Although early breast cancer (BC) is highly curable, advanced or metastatic disease poses numerous challenges in terms of medical management and treatment... https://pubmed.ncbi.nlm.nih.gov/33302999/ Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual... Our data support the hypothesis that the addition of pertuzumab to trastuzumab reduces the amount of available plasma membrane HER2 receptor, limiting the...